Medgend Icon

Ledgend of Medicine







discontinued


Fibro

Fibromyalgia is chronic (long-lasting) condition that causes pain all over the body, fatigue, and other symptoms. There is no cure, but treatments can help with the symptoms.

What causes fibromyalgia?

The exact cause of fibromyalgia is unknown. Studies of the brains of people with fibromyalgia found that they seem to process pain differently than people who don't have it. They may feel pain when others do not, and they may also have a more severe reaction to pain.

Fibromyalgia can run in families, so genetics may also play a role. Other factors may also be involved, such as having certain diseases that cause pain.

Who is at risk for fibromyalgia?

Anyone can get fibromyalgia, but it is more common in:

  • Women; they are twice as likely to have fibromyalgia
  • Middle-aged people; your chance of having it increases as you get older
  • People with certain diseases, such as lupus, rheumatoid arthritis, osteoarthritis or ankylosing spondylitis
  • People who have a family member with fibromyalgia
What are the symptoms of fibromyalgia?

The main symptoms of fibromyalgia are:

  • Chronic (long-lasting) pain and stiffness all over the body. People often describe it as aching, burning, or throbbing.
  • Fatigue and tiredness.
  • Trouble sleeping.

Other symptoms may include:

  • Problems with thinking, memory, and concentration (sometimes called "fibro fog")
  • Muscle and joint stiffness
  • Numbness or tingling in the arms and legs
  • Sensitivity to light, noise, odors, and temperature

People who have fibromyalgia are also more likely to have certain diseases, including:

  • Anxiety
  • Depression
  • Headaches, including migraines
  • Irritable bowel syndrome
  • Pain in the face or jaw, including disorders of the jaw know as temporomandibular joint syndrome (TMJ)
How is fibromyalgia diagnosed?

Fibromyalgia can be hard to diagnose. It sometimes takes visits to several different health care providers to get a diagnosis. One problem is that there isn't a specific test for it. And the main symptoms, pain and fatigue, are common in many other conditions. Providers have to rule out other causes of the symptoms before making a diagnosis of fibromyalgia. This is called making a differential diagnosis.

To find out if you have fibromyalgia, your provider:

  • Will take your medical history, including asking detailed questions about your symptoms
  • Will do a physical exam
  • May order x-rays and blood tests to rule out other conditions
What are the treatments for fibromyalgia?

Not all providers are familiar with fibromyalgia and its treatment. You should see a provider or team of providers who specialize in the treatment of fibromyalgia.

There is no cure for fibromyalgia, so treatment focuses on relieving the symptoms. Providers usually use a combination of treatments, including medicines, lifestyle changes, talk therapy, and complementary therapies:

  • Medicines
    • Certain antidepressants and anti-seizure medicines, which may help with pain or sleep problems.
    • Pain relievers.
  • Lifestyle changes
    • Getting enough sleep.
    • Getting regular physical activity. If you have not already been active, start slowly and gradually increase how much activity you get. You may want to see a physical therapist, who can help you create a plan that is right for you.
    • Learning how to manage stress.
    • Learning to pace yourself. If you do too much, it can make your symptoms worse. So you need to learn to balance being active with your need for rest.
  • Talk therapy, such as cognitive behavioral therapy (CBT), can help you learn strategies to deal with pain, stress, and negative thoughts. If you also have depression along with your fibromyalgia, talk therapy can help with that too.
  • Complementary therapies have helped some people with the symptoms of fibromyalgia. But researchers need to do more studies to show which ones are effective. You could consider trying them, but you should check with your provider first. These therapies include:
    • Mindfulness meditation.
    • Biofeedback, which uses electronic devices to measure body functions such as breathing and heart rate. This teaches you to be more aware of your body functions so you can learn to control them.
    • Movement therapies such as yoga and tai chi.
    • Massage therapy.
    • Acupuncture.

Fibro FDA Approved Drugs

BETHKIS [TobramycinC18H37N5O9]
RX
-
300mg/4ml (inhalation solution)
Chiesi Usa IncOct 12, 2012
  • Management of cystic fibrosis patients.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CAYSTON [AztreonamC13H17N5O8S2]
RX
-
75mg/vial (inhalation for solution)
GileadFeb 22, 2010
  • Improve respiratory symptoms in cystic fibrosis in patients with pseudomonas aeruginosa.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CYMBALTA [Duloxetine HydrochlorideC18H19NOSClH]
RX
-
eq 20mg base (oral capsule, delayed rel pellets)
eq 30mg base (oral capsule, delayed rel pellets)
eq 60mg base (oral capsule, delayed rel pellets)
LillyAug 3, 2004
  • Management of fibromyalgia (fm).
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DEFITELIO [Defibrotide Sodium(C10H12N2O7P)n(C10H11N5O5P)n(C10H11N5O6P)n(C9H11N3O6P)n4Na]
RX
-
200mg/2.5ml (80mg/ml) (iv (infusion) solution)
Jazz Pharms IncMar 30, 2016
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ESBRIET [PirfenidoneC12H11NO]
RX
-
267mg (oral tablet)
801mg (oral tablet)
Genentech IncJan 11, 2017
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

GEMFIBROZIL [GemfibrozilC15H22O3]
RX
-
600mg (oral tablet)
ApotexJul 20, 1998
Aurobindo Pharma LtdSep 16, 2015
Cadila Pharms LtdJun 17, 2016
Caribe HoldingsMar 26, 2007
Chartwell MoleculesSep 27, 1993
Hikma PharmsAug 16, 2010
Impax PharmsJun 1, 2007
Invagen PharmsJul 27, 2006
Northstar HlthcareSep 13, 2010
Sun Pharm Inds IncDec 29, 2008
TevaOct 31, 1993
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

JAKAFI [Ruxolitinib PhosphateC17H18N6H3O4P]
RX
-
eq 10mg base (oral tablet)
eq 15mg base (oral tablet)
eq 20mg base (oral tablet)
eq 25mg base (oral tablet)
eq 5mg base (oral tablet)
Incyte CorpNov 16, 2011
  • For the treatment of intermediate or high-risk myelofibrosis.
  • For the treatment of polycythemia vera.
  • Use of ruxolitinib (jakafi) for blocking signal transduction of janus associated kinases (jaks) jak1 and/or jak2.
  • Use of ruxolitinib (jakafi) for inhibiting janus associated kinases (jaks) jak1 and/or jak2..
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KALYDECO [IvacaftorC24H28N2O3]
RX
-
150mg (oral tablet)
50mg/packet (oral granule)
75mg/packet (oral granule)
Vertex PharmsJan 31, 2012
Vertex Pharms IncMar 17, 2015
  • Method of treating a patient having cystic fibrosis, such as a patient having a g551d mutation in cftr, using n-(5-hydroxy-2,4-di-tert-butyl-phenyl)-4-oxo-1h-quinoline-3-carboxamide.
  • Method of treating a patient having cystic fibrosis, the patient having a r117h mutation in cftr, using n-(5-hydroxy-2,4-di-tert-butyl-phenyl)-4-oxo-1h-quinoline-3-carboxamide.
  • Method of treating cystic fibrosis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LOPID [GemfibrozilC15H22O3]
RX
-
600mg (oral tablet)
Pfizer PharmsNov 20, 1986
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LYRICA [PregabalinC8H17NO2]
RX
-
100mg (oral capsule)
150mg (oral capsule)
200mg (oral capsule)
20mg/ml (oral solution)
225mg (oral capsule)
300mg (oral capsule)
75mg (oral capsule)
Pf Prism CvDec 30, 2004
  • Management of fibromyalgia.
  • Treatment of pain, including neuropathic pain associated with diabetic peripheral neuropathy or spinal cord injury, postherpetic neuralgia, and fibromyalgia.
  • Treatment of pain.
efficacy
5.0  (2)
side effects
1.0  (2)
danger
0.0  (0)

UNK

OFEV [Nintedanib EsylateC31H33N5O4C2H6O3S]
RX
-
eq 100mg base (oral capsule)
eq 150mg base (oral capsule)
Boehringer IngelheimOct 15, 2014
  • Treatment of idiopathic pulmonary fibrosis (ipf).
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ORKAMBI [IvacaftorC24H28N2O3 : LumacaftorC24H18F2N2O5]
RX
-
125mg : 100mg (oral tablet)
125mg : 200mg (oral tablet)
Vertex Pharms IncSep 28, 2016
  • Method of treating a patient having cystic fibrosis using ivacaftor and lumacaftor.
  • Method of treating cystic fibrosis in a patient, the patient having the f508del mutation in cftr, using a dosage unit as defined in claim 1 of u.s. patent no. 9,192,606.
  • Method of treating cystic fibrosis in a patient, the patient having the f508del mutation in cftr, using ivacaftor and form i lumacaftor.
  • Method of treating cystic fibrosis in a patient, the patient having the f508del mutation in cftr, using ivacaftor and lumacaftor.
  • Method of treating cystic fibrosis in a patient, the patient having the f508del mutation in cftr, using the dosage unit of claim 1 of u.s. patent no. 8,716,338.
  • Method of treating cystic fibrosis in patients who are homozygous for the f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.
  • Method of treating cystic fibrosis in patients who have the f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene..
  • Method of treating cystic fibrosis using n-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1h-quinoline-3-carboxamide and 3-(6-(1-2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid.
  • Method of treating cystic fibrosis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SAVELLA [Milnacipran HydrochlorideC15H22N2OClH]
RX
-
100mg (oral tablet)
12.5mg (oral tablet)
25mg (oral tablet)
50mg (oral tablet)
Allergan Sales LlcJan 14, 2009
  • Management of fibromyalgia (fm).
  • Management of fibromyalgia.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TOBI PODHALER [TobramycinC18H37N5O9]
RX
-
28mg (inhalation powder)
NovartisMar 22, 2013
  • Treatment of cystic fibrosis patients with pseudomonas aeruginosa.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ZENPEP [Pancrelipase (amylase : Lipase : Protease)]
RX
-
109,000usp units : 20,000usp units : 68,000usp units (oral capsule, delayed release)
136,000usp units : 25,000usp units : 85,000usp units (oral capsule, delayed release)
16,000usp units : 3,000usp units : 10,000usp units (oral capsule, delayed release)
218,000usp units : 40,00usp units : 136,000 usp units (oral capsule, delayed release)
27,000usp units : 5,000usp units : 17,000usp units (oral capsule, delayed release)
55,000usp units : 10,000usp units : 34,000usp units (oral capsule, delayed release)
82,000usp units : 15,000usp units : 51,000usp units (oral capsule, delayed release)
Forest Labs IncAug 27, 2009
  • Treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for reference only. Many of these treatments may be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field. The owner of this website will not be held liable for any injuries and deaths cause by following any home remedies. We have no control of what is posted.

Home Remedies for Fibro

SCAR REDUCTION [fibrosis]
   Apply coconut oil, cocoa butter, castor oil or vitamin E oil as soon as the wound closes.Jlaiii | August 12th, 2020
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Felter's Materia Medica on Fibro

CINNAMOMUM
   I. Cinnamomum Saigonicum. Dried bark of an undetermined species of Cinnamomum. Chiefly from China. II. Cinnamomum Zeylanicum. Dried bark of... / ...s a preferred preparation. Oil of erigeron acts very well with it. In menorrhagia, even when due to fibroids and polypi, it has had the effect of intermittently checking the waste: but only a surgical...2

GOSSYPIUM
   The bark of the root and the hairs of the seed of Gossypium herbaceum, Linné, and of other species of Gossypium (Nat. Ord. Malvaceae). An Asiatic... / ...ine musculature it is of value in uterine subinvolution and is asserted to have reduced the size of fibroids. It probably acts much in the same manner as ergot, though far less powerfully. It has the ...2

PHYTOLACCA
   ...those of the mouth, throat, sexual system, and very markedly upon the mammary glands; also upon the fibrous and serous tissues, and mucous membranes of the digestive and urinary tracts. It is principa......he tonsils, ovaries, testicles, and mammary glands, we are well satisfied. The periosteal and other fibrous tissues are also acted upon by it, and there is no doubt but that it has more or less influe...2

VIBURNUM PRUNIFOLIUMVIPR2
   The dried bark of the root of Viburnum prunifolium, Linné. The U.S.P. admits the dried bark of this and also of the Viburnum Lentago, Linné, or... / ...As a remedy for passive hemorrhage its use will be governed largely by the cause. If due to polypi, fibroid or carcinomatous tumors, but little can be expected from it or any other medicine. But even ...2


References

1) Bergner, Pal., Griswold, Alexandra F., Hufford, David J., et al. . Morton Grove, Il: Publications International, 2017.
2) Felter, Harvey Wickes, 1922, The Eclectic Materia Medica, Pharmacology and Therapeutics, Cincinnati, Ohio.